MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGEN EXPRESSION ON PARENCHYMAL-CELLS OF THYROID ALLOGRAFTS IS NOT BY ITSELF SUFFICIENT TO INDUCE REJECTION

被引:23
作者
LAROSA, FG [1 ]
TALMAGE, DW [1 ]
机构
[1] UNIV COLORADO,HLTH SCI CTR,HLTH SCI CTR,WEBB WARING INST,DENVER,CO 80262
关键词
D O I
10.1097/00007890-199003000-00024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
H-2d thyroids cultured in oxygen at normal atmospheric pressure (suboptimal culture) were grafted into H-2b mice. Some of these tissues were cultured with recombinant mouse gamma-interferon (rIFN), and they expressed high levels of major histocompatibility complex antigens before grafting. Three weeks later, no difference in the rate of rejection of MHC-induced grafts was observed as compared with uninduced tissues (50% of each group). Fresh (uncultured) grafts were uniformly rejected inless than 2 weeks. Also, H-2d thyroids, freed of donor leukocytes by preculture in hyperbaric oxygen and more than 1 year parking in normal H-2b recipients, were incubated with and without rIFN, and then grafted into normal H-2b mice; 100% acceptance was observed in both groups regardless of the expression of allo-MHC molecules on thyroid cells. In another set of experiments, using grafts with a single antigenic difference at the MHC locus (bml into B6), graft rejection was observed only when the recipients were immunized with donor spleen cells and fresh tissues were implanted. In the same immune recipients, cultured and MHC-induced thyroids grafted in the opposite kidney were, in general, not rejected. These results demonstrated that the expression of allo- MHC molecules on graft cells was not by itself sufficient to engender tissue immunogenicity. This supports our previous hypothesis that the main effect of tissue culture is the inactivation of passenger leukocytes. MHC antigens appear to be immunogenic only when properly presented by these cells. © 1990 by Williams & Wilkins.
引用
收藏
页码:605 / 609
页数:5
相关论文
共 24 条
  • [1] MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I AND CLASS-II EXPRESSION BY MYOCYTES IN CARDIAC BIOPSIES POSTTRANSPLANTATION
    AHMEDANSARI, A
    TADROS, TS
    KNOPF, WD
    MURPHY, DA
    HERTZLER, G
    FEIGHAN, J
    LEATHERBURY, A
    SELL, KW
    [J]. TRANSPLANTATION, 1988, 45 (05) : 972 - 978
  • [2] AREND WP, 1988, CLIN EXP IMMUNOL, V74, P377
  • [3] ARENZANASEISDEDOS F, 1985, J IMMUNOL, V134, P2444
  • [4] PREVENTION OF REJECTION OF MURINE ISLET ALLOGRAFTS BY PRETREATMENT WITH ANTI-DENDRITIC CELL ANTIBODY
    FAUSTMAN, DL
    STEINMAN, RM
    GEBEL, HM
    HAUPTFELD, V
    DAVIE, JM
    LACY, PE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (12): : 3864 - 3868
  • [5] HAO L, 1989, TRANSPLANT P, V21, P2679
  • [6] HARDY MA, 1985, TRANSPLANT P, V17, P423
  • [7] ENHANCEMENT OF THYROID ALLOGRAFT SURVIVAL FOLLOWING ORGAN-CULTURE - ALTERATION OF TISSUE IMMUNOGENICITY
    HULLETT, DA
    LANDRY, AS
    LEONARD, DK
    SOLLINGER, HW
    [J]. TRANSPLANTATION, 1989, 47 (01) : 24 - 27
  • [8] OVARIAN ALLOGRAFT SURVIVAL - PROLONGATION AFTER PASSAGE INVITRO
    JACOBS, BB
    [J]. TRANSPLANTATION, 1974, 18 (05) : 454 - 457
  • [9] ANTIGEN-INDUCIBLE, H-2-RESTRICTED, INTERLEUKIN-2-PRODUCING T-CELL HYBRIDOMAS - LACK OF INDEPENDENT ANTIGEN AND H-2 RECOGNITION
    KAPPLER, JW
    SKIDMORE, B
    WHITE, J
    MARRACK, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 153 (05) : 1198 - 1214
  • [10] Kohler G., 1981, IMMUNE SYSTEM, V2, P202